Gardasil, a quadrivalent human papilloma virus (HPV) type 6, 11, 16 and 18 vaccine has been successfully launched by MSD in India. It is the country's first vaccine to help prevent cervical cancer caused by the HPV types. The vaccine also helps prevent diseases abnormal and precancerous cervical lesions, vaginal lesions, vulvar lesions, and genital warts caused by the virus. It is also the only USFDA approved vaccine to help prevent cervical cancer and other diseases caused by HPV types. Gardasil is recommended to be given to females aged between nine to 26 years.
No comments:
Post a Comment